
Roger Pebody
Medical Writer and Editor at Freelance
Medical journalist: aidsmap, The Lancet HIV, Medscape, TheBodyPro
Articles
-
1 week ago |
thelancet.com | Roger Pebody
In a provincial Mexican city, a young gay man wakes up on a Saturday morning, recalls the events of the previous night and realises that he needs post-exposure prophylaxis (PEP). He's not sure if he can get it locally, especially with health services closed for the weekend, and he's worried about doctors judging him. As he only knows about PEP from Instagram posts by a group called VIHve Libre , he sends them a message.
-
3 weeks ago |
medscape.com | Roger Pebody
An artificial intelligence (AI) model using routinely collected data predicted subsequent development of active tuberculosis (TB), Swiss researchers reported. The AI model outperformed biological tests for latent TB in identifying HIV-positive patients at high risk of developing TB. As well as immune function and sociodemographic variables, the AI model retained several biomarkers indicative of patients’ well-being and metabolism.
-
2 months ago |
aidsmap.com | Roger Pebody
Estimated reading time 3 minutes While some countries have already shifted to less intensive monitoring requirements for PrEP users, a Dutch study has now provided evidence that it’s OK to test for sexually transmitted infections (STIs) every six months, to have clinic appointments at the same rhythm and for services to be delivered online. Simplified, less burdensome services had just as good outcomes as the standard of care.
-
Mar 5, 2025 |
espanol.medscape.com | Roger Pebody
Una calculadora de riesgo cardiovascular utilizada habitualmente por los profesionales médicos subestima el riesgo para las mujeres y las personas afrodescendientes que viven con infección por virus de inmunodeficiencia humana en los países de ingresos altos, mientras que sobreestima el riesgo para las personas con dicho virus en los países de ingresos bajos y medios.[1] Las puntuaciones de riesgo son un factor clave en las recomendaciones de las guías para la prescripción de estatinas y...
-
Feb 26, 2025 |
medscape.com | Roger Pebody
Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, research suggests. Currently, the intramuscular injections are provided by healthcare professionals. The new research might make self-injection of this antiretroviral therapy (ART) a more feasible option.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 2K
- DMs Open
- No

RT @EATGx: We are glad to publish the reports from the #HIVGlasgow2024 Congress on our bulletin and website. ⤵️ Check out the website (tag…

RT @NAT_AIDS_Trust: We are delighted that Manuel Guerrero, the British citizen living with HIV arrested in #Qatar, is finally free in Londo…

RT @juliewreynolds1: Listen louder to this.